참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | Sodium Hydroxide | HCID 14798 | — |
| 반응물 | O-benzylglycine toluene-p-sulphonate | HCID 6451311 | — |
| 반응물 | 1-Butanaminium, N,N,N-tributyl-, carbonic acid (1:1) | HCID 11012140 | — |
| 반응물 | 2,5-Dibromopentanoyl chloride | HCID 11185032 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | (3-Bromo-2-oxo-piperidin-1-yl)acetic acid benzyl ester | HCID 69484297 | — |
반응 단계
67.7 g (0.2 mol) of glycine benzyl ester tosylate and 61.2 ml (0.44 mol) of triethylamine are dissolved in 200 ml of methylene chloride and added in drops at 0° C. to a solution of 55.7 g (0.2 mol) of 2,5-dibromovaleric acid chloride (Okawara et al. Chem. Pharm. Bull. (1982), (30), 1225) in 200 ml of methylene chloride within 45 minutes, and it is stirred for 18 hours at room temperature. The reaction mixture is now added in drops at 0° C. to a solution of 400 ml of aqueous 32% sodium hydroxide and 2 g of tetrabutylammonium hydrogen carbonate (about 15 minutes), and it is stirred for 30 minutes. Then, the phases are separated, and the aqueous phase is extracted three times with 200 ml of dichloromethane each. The organic phases are dried on sodium sulfate, the solution is evaporated to the dry state and chromatographed on silica gel (methylene chloride). The fractions that contain the product are combined and concentrated by evaporation.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07164016B2 |
|---|
| 출처 데이터셋 | uspto-grants-2007_01 |
|---|
| ORD ID | ord-9da6f88e5c9d425f975ad89bb11f4551 |
|---|
| 출처 메모 | uspto-grants-2007_01 |
|---|